In 1932, seven burials have been found on a Texas plantation that was initially the location of a 17th-century Caddo Indian village. Of the seven excavated graves, one set of stays (an grownup male) was notably buried in a way inconsistent with conventional Caddoan burial practices and has lengthy been presupposed to be the stays of Sieur de Marle (a member of the French explorer La Salle’s final expedition). Diary accounts of La Salle’s expedition scribe report that Sieur de Marle died alongside a river close to an Indian village throughout a trek to Canada to search out assist for colonists left behind on the ill-fated Fort St. Louis. Moreover, two lead projectiles recovered from the grave have been ballistically analyzed and decided to be per ammunition utilized in 17th-century weaponry.
Within the 1980s, anthropologists requested entry to the stays for examine, however the cranium was lacking. Cranial measurements recorded in 1940 and 1962 (by two unbiased anthropologists) have been used to analyze the ancestry of this particular person; and the Giles-Elliot (G-E) discriminant perform was calculated to be 18.1, throughout the Anglo-European vary. Dietary isotope testing on non-cranial skeletal components decided that this unknown male’s weight-reduction plan was wealthy in animal/marine protein sources, which differs appreciably from Caddo Indian populations of that point interval. With a view to genetically assess this particular person’s biogeographic ancestry and to offer additional help that this particular person is of European descent, mitochondrial DNA (mtDNA) sequencing was carried out utilizing the Utilized Biosystems™ Precision ID mtDNA Entire Genome Panel. mtDNA sequencing of a number of sections from two totally different lengthy bones yielded compiled outcomes per both Haplogroup H or R, each predominantly European mtDNA haplogroups.
Additional anthropological calculations have been performed utilizing cranial measurements, FORDISC™ software program, and discriminant perform evaluation. Two-way, four-way, and multigroup discriminant perform analyses additional classify this set of unidentified stays as being White (European) in origin, with posterior chances of 0.999, 0.881 and 0.986, respectively. Mixed with historic data of Sieur de Marle’s loss of life, in addition to overlays of historic and up to date maps which exhibit that the plantation web site aligns with Joutel’s diary accounts of de Marle’s burial, these collective outcomes help that these stays are of a European male and will presumably belong to this distinguished member of La Salle’s expedition staff.
Design, Synthesis and Analysis of two,4,6-substituted Pyrimidine Derivatives as BACE-1 inhibitor: Believable lead for Alzheimer’s Illness
Alzheimer’s illness is likely one of the most typical neurodegenerative dysfunction afflicting a big mass of inhabitants. BACE-1 (β-secretase) is an aspartyl protease of the amyloidogenic pathway thought-about liable for Alzheimer’s illness (AD). Since, it catalyzes the speed limiting step of Aβ-42 manufacturing from amyloid precursor protein (APP),its inhibition is taken into account a viable therapeutic technique. We’ve reported the design of small molecular weight compounds speculated to be blood mind permeable as BACE-1 inhibitors. The clue for the design of this sequence is drawn from the beforehand designed sequence from our analysis group.Design and synthesis of two,4,6-substituted pyrimidine derivatives has been reported. In vitro FRET primarily based screening of synthesized derivatives was carried out to guage the BACE-1 inhibition profile.
Primarily based on the docking simulation research, a library of derivatives was designed, synthesized and evaluated for BACE-1 inhibition in-vitro. The docking research have been carried out on Glide (Schrodinger suite) and Molegro digital docker. Theoretical toxicity was predicted utilizing Osiris Property Explorer. The synthesized compounds have been examined for BACE-1 inhibition utilizing in vitro assay primarily based on Fluorescence Resonance Power Switch approach. The % inhibition was calculated as a measure of exercise.
The designed compounds revealed robust interactions with the specified amino acids of BACE-1 lively websites. The fragrant rings positioned at fourth and sixth place of pyrimidine ring occupied S1 and S3 substrate binding clefts whereas the amino group fashioned hydrogen bonding interactions with Asp32 and Asp228. In silico information ensured that the compounds have been orally bioavailable and mind permeable. The in vitro testing confirmed that the compounds inhibited BACE-1 at 10µM focus.
Compounds substituted with m-benzyloxy on one fragrant ring and o,p-di-chloro on one other fragrant ring displayed most BACE-1 inhibition. Compound 2.13A displayed excessive docking rating and was discovered to be most potent with IC50 of 6.92µM. The sequence displayed correlation between docking rating and BACE-1 inhibition profile.
PAWER: protein array internet exploreR
Protein microarray is a well-established strategy for characterizing exercise ranges of 1000’s of proteins in a parallel method. Evaluation of protein microarray information is advanced and time-consuming, whereas present options are both outdated or difficult to make use of with out programming expertise. The standard information evaluation pipeline consists of a knowledge preprocessing step, adopted by differential expression evaluation, which is then put into context by way of purposeful enrichment. Usually, biologists would wish to assemble their very own workflow by combining a set of unrelated instruments to investigate experimental information. Supplied that the majority of those instruments are developed independently by varied bioinformatics teams, making them work collectively might be an actual problem.
Recombinant Human APOE4 Protein, His, E.coli-100ug |
QP11051-100ug |
EnQuireBio |
100ug |
EUR 186 |
Recombinant Human APOE4 Protein, His, E.coli-500ug |
QP11051-500ug |
EnQuireBio |
500ug |
EUR 284.4 |
APOE4 Apolipoprotein E4 Human Recombinant Protein |
PROTP02649-1 |
BosterBio |
Regular: 500ug |
EUR 402 |
Description: Apolipoprotein E4 Human Recombinant produced in E.coli is a single, non-glycosylated polypeptide chain containing a total of 306 amino acids including a His Tag at N-terminus and having a molecular mass of 35.2kDa. The Accession # is P02649 VAR_000652. |
ApoE4 Antibody |
5699-100 |
Biovision |
each |
EUR 398.4 |
ApoE4 Antibody |
5699-30T |
Biovision |
each |
EUR 175.2 |
ApoE4 antibody |
70R-12420 |
Fitzgerald |
100 ug |
EUR 483.6 |
Description: Rabbit polyclonal ApoE4 antibody |
Human Apolipoprotein E / APOE4 Protein, His Tag (MALS verified) |
APE-H52H9 |
ACROBIOSYSTEMS |
100ug |
EUR 2493.1 |
|
Description: Human APOE4, His Tag (APE-H52H9) is expressed from human 293 cells (HEK293). It contains AA Lys 19 - His 317 (Accession # P02649-1 (C130R)). |
Human Apolipoprotein E / APOE4 Protein, Tag Free (MALS verified) |
APE-H5215 |
ACROBIOSYSTEMS |
100ug |
EUR 2493.1 |
|
Description: Human APOE4 Protein, Tag Free (APE-H5215) is expressed from human 293 cells (HEK293). It contains AA Lys 19 - His 317 (Accession # P02649-1 (C130R)). |
ApoE4, human recombinant |
4699-100 |
Biovision |
each |
EUR 170.4 |
ApoE4, human recombinant |
4699-1000 |
Biovision |
each |
EUR 548.4 |
ApoE4, human recombinant |
4699-50 |
Biovision |
each |
EUR 151.2 |
ApoE4, human recombinant |
4699-500 |
Biovision |
each |
EUR 339.6 |
ApoE4, human recombinant |
4699-5000 |
Biovision |
each |
EUR 1776 |
Biotinylated Human Apolipoprotein E / APOE4 Protein, His,Avitag™ (MALS verified) |
APE-H52E7 |
ACROBIOSYSTEMS |
25ug |
EUR 1487.3 |
|
Description: Biotinylated Human APOE4 His,Avitag (APE-H52E7) is expressed from human 293 cells (HEK293). It contains AA Lys 19 - His 317 (Accession # P02649-1 (C130R)). |
ApoE3 protein |
30R-2381 |
Fitzgerald |
1 mg |
EUR 711.6 |
Description: Purified recombinant Human ApoE3 protein |
ApoE2 protein |
30R-2387 |
Fitzgerald |
1 mg |
EUR 669.6 |
Description: Purified recombinant Human ApoE2 protein |
ApoE3 protein |
30R-AA016 |
Fitzgerald |
500 ug |
EUR 327.6 |
Description: Purified recombinant Human ApoE3 protein |
ApoE2 protein |
30R-AA019 |
Fitzgerald |
500 ug |
EUR 327.6 |
Description: Purified recombinant Human ApoE2 protein |
Recombinant Human ApoE2 Protein |
PROTP02649-2 |
BosterBio |
500ug |
EUR 380.4 |
Description: ApoE belongs to a group of proteins that bind reversibly with lipoprotein and play an important role in lipid metabolism. In addition to facilitating solublization of lipids, these proteins help to maintain the structural integrity of lipoproteins, serve as ligands for lipoprotein receptors, and regulate the activity of enzymes involved in lipid metabolism. Significant quantities of ApoE are produced in liver and brain and to some extent in almost every organ. ApoE is an important constituent of all plasma lipoproteins. It’s interaction with specific ApoE receptor enables uptake of chylomicron remnants by liver cells, which is an essential step during normal lipid metabolism. It also binds with the LDL receptor (apo B/E). Defects in ApoE are a cause of hyperlipoproteinemia type III. ApoE exists in three major isoforms; E2, E3, and E4, which differ from one another by a single amino-acid substitution. Compared with E3 and E4, E2 exhibits the lowest receptor binding affinity. E2 allele carriers had significantly lower levels of total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol, as well as increased ApoE levels. Recombinant human ApoE2 is a 34.3 kDa protein containing 300 amino acid residues. |
Recombinant Human ApoE3 Protein |
PROTP02649-3 |
BosterBio |
500ug |
EUR 380.4 |
Description: ApoE3 belongs to a group of proteins that bind reversibly with lipoprotein and play an important role in lipid metabolism. In addition to facilitating solublization of lipids, these proteins help to maintain the structural integrity of lipoproteins, serve as ligands for lipoprotein receptors, and regulate the activity of enzymes involved in lipid metabolism. Significant quantities of ApoE are produced in liver and brain and to some extent in almost every organ. ApoE exists in three major isoforms; E2, E3, and E4, which differ from one another by a single amino-acid substitution. E3 is the most common isoform and is present in 40-90% of the population. Recombinant human ApoE3 is a 34.0 kDa protein containing 299 amino acid residues. |
ApoE protein |
30-AA30 |
Fitzgerald |
100 ug |
EUR 936 |
Description: Purified native Human ApoE protein |
ApoE protein |
30-1053 |
Fitzgerald |
50 ug |
EUR 1278 |
Description: Purified native Human ApoE protein |
ApoE3 Recombinant Protein |
40-136-01mg |
ProSci |
0.1 mg |
EUR 311.1 |
Description: ApoE3 belongs to a group of proteins that bind reversibly with lipoprotein and play an important role in lipid metabolism. In addition to facilitating solublization of lipids, these proteins help to maintain the structural integrity of lipoproteins, serve as ligands for lipoprotein receptors, and regulate the activity of enzymes involved in lipid metabolism. Significant quantities of ApoE are produced in liver and brain and to some extent in almost every organ. ApoE exists in three major isoforms; E2, E3, and E4, which differ from one another by a single amino-acid substitution. E3 is the most common isoform and is present in 40-90% of the population. Recombinant human ApoE3 is a 34.4 kDa protein containing 300 amino acid residues. |
ApoE3 Recombinant Protein |
40-136-05mg |
ProSci |
0.5 mg |
EUR 437.1 |
Description: ApoE3 belongs to a group of proteins that bind reversibly with lipoprotein and play an important role in lipid metabolism. In addition to facilitating solublization of lipids, these proteins help to maintain the structural integrity of lipoproteins, serve as ligands for lipoprotein receptors, and regulate the activity of enzymes involved in lipid metabolism. Significant quantities of ApoE are produced in liver and brain and to some extent in almost every organ. ApoE exists in three major isoforms; E2, E3, and E4, which differ from one another by a single amino-acid substitution. E3 is the most common isoform and is present in 40-90% of the population. Recombinant human ApoE3 is a 34.4 kDa protein containing 300 amino acid residues. |
ApoE2 Recombinant Protein |
40-140-01mg |
ProSci |
0.1 mg |
EUR 311.1 |
Description: ApoE belongs to a group of proteins that bind reversibly with lipoprotein and play an important role in lipid metabolism. In addition to facilitating solublization of lipids, these proteins help to maintain the structural integrity of lipoproteins, serve as ligands for lipoprotein receptors, and regulate the activity of enzymes involved in lipid metabolism. Significant quantities of ApoE are produced in liver and brain and to some extent in almost every organ. ApoE is an important constituent of all plasma lipoproteins. It’s interaction with specific ApoE receptor enables uptake of chylomicron remnants by liver cells, which is an essential step during normal lipid metabolism. It also binds with the LDL receptor (apo B/E). Defects in ApoE are a cause of hyperlipoproteinemia type III. ApoE exists in three major isoforms; E2, E3, and E4, which differ from one another by a single amino-acid substitution. Compared with E3 and E4, E2 exhibits the lowest receptor binding affinity. E2 allele carriers had significantly lower levels of total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol, as well as increased ApoE levels. Recombinant human ApoE2 is a 34.3 kDa protein containing 300 amino acid residues. |
ApoE2 Recombinant Protein |
40-140-05mg |
ProSci |
0.5 mg |
EUR 437.1 |
Description: ApoE belongs to a group of proteins that bind reversibly with lipoprotein and play an important role in lipid metabolism. In addition to facilitating solublization of lipids, these proteins help to maintain the structural integrity of lipoproteins, serve as ligands for lipoprotein receptors, and regulate the activity of enzymes involved in lipid metabolism. Significant quantities of ApoE are produced in liver and brain and to some extent in almost every organ. ApoE is an important constituent of all plasma lipoproteins. It’s interaction with specific ApoE receptor enables uptake of chylomicron remnants by liver cells, which is an essential step during normal lipid metabolism. It also binds with the LDL receptor (apo B/E). Defects in ApoE are a cause of hyperlipoproteinemia type III. ApoE exists in three major isoforms; E2, E3, and E4, which differ from one another by a single amino-acid substitution. Compared with E3 and E4, E2 exhibits the lowest receptor binding affinity. E2 allele carriers had significantly lower levels of total cholesterol, low-density lipoprotein cholesterol, and non-high-density lipoprotein cholesterol, as well as increased ApoE levels. Recombinant human ApoE2 is a 34.3 kDa protein containing 300 amino acid residues. |
Human Apolipoprotein E / APOE3 Protein, His Tag |
APE-H5246 |
ACROBIOSYSTEMS |
100ug |
EUR 2471.7 |
|
Description: Human APOE3, His Tag (APE-H5246) is expressed from human 293 cells (HEK293). It contains AA Lys 19 - His 317 (Accession # P02649-1). |
Rabbit Anti-Human ApoE3 protein antiserum #1 |
APOE31-S |
Alpha Diagnostics |
100 ul |
EUR 548.4 |
Recombinant Human APOE3 Protein, His, E.coli-1mg |
QP10522-1mg |
EnQuireBio |
1mg |
EUR 381.6 |
Recombinant Human APOE3 Protein, His, E.coli-100ug |
QP10522-100ug |
EnQuireBio |
100ug |
EUR 186 |
Recombinant Human APOE3 Protein, His, E.coli-500ug |
QP10522-500ug |
EnQuireBio |
500ug |
EUR 241.2 |
Human Apolipoprotein E / APOE2 Protein, His Tag (SPR verified) |
APE-H52H6 |
ACROBIOSYSTEMS |
100ug |
EUR 2140 |
|
Description: Human APOE2, His Tag (APE-H52H6) is expressed from human 293 cells (HEK293). It contains AA Lys 19 - His 317 (Accession # P02649-1 (R176C)). |
Human Apolipoprotein E / APOE3 Protein, Tag Free (MALS verified) |
APE-H5213 |
ACROBIOSYSTEMS |
1mg |
EUR 2471.7 |
|
Description: Human APOE3 Protein, Tag Free (APE-H5213) is expressed from human 293 cells (HEK293). It contains AA Lys 19 - His 317 (Accession # P02649-1). |
Human Apolipoprotein E / APOE3 Protein, Tag Free (MALS verified) |
APE-H5216 |
ACROBIOSYSTEMS |
100ug |
EUR 2471.7 |
|
Description: Human APOE3 Protein, Tag Free (APE-H5216) is expressed from human 293 cells (HEK293). It contains AA Lys 19 - His 317 (Accession # P02649-1 ). |
Human ApoE2 Recombinant Protein Lyophilized |
IHUAPOE2RLY100UG |
Innovative research |
each |
EUR 341 |
|
Description: Human ApoE2 Recombinant Protein Lyophilized |
Human ApoE3 Recombinant Protein Lyophilized |
IHUAPOE3RLY100UG |
Innovative research |
each |
EUR 341 |
|
Description: Human ApoE3 Recombinant Protein Lyophilized |
Human APOE Protein Lysate 20ug |
IHUAPOEPLLY20UG |
Innovative research |
each |
EUR 213 |
|
Description: Human APOE Protein Lysate 20ug |
Human Apolipoprotein E / APOE2 (R154S) Protein, His Tag |
APE-H5256 |
ACROBIOSYSTEMS |
100ug |
EUR 2749.9 |
|
Description: Human APOE2 (R154S), His Tag (APE-H5256) is expressed from human 293 cells (HEK293). It contains AA Lys 19 - His 317 (Accession # P02649-1 (R154S)). |
APOE3 Apolipoprotein E3 Human Recombinant Protein |
PROTP02649 |
BosterBio |
Regular: 500ug |
EUR 380.4 |
Description: APOE3 Human Recombinant (19-317) produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 306 amino acids and having a molecular mass of 35kDa.;The APOE is fused to a 7 amino acid His tag [M-HHHHHH] at N-terminus and purified by proprietary chromatographic techniques. |
Dog Apolipoprotein E (APOE) Protein |
20-abx168028 |
Abbexa |
-
EUR 927.60
-
EUR 360.00
-
EUR 2932.80
-
EUR 1111.20
-
EUR 661.20
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Rat Apolipoprotein E (APOE) Protein |
20-abx065427 |
Abbexa |
-
EUR 878.40
-
EUR 343.20
-
EUR 2766.00
-
EUR 1062.00
-
EUR 627.60
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Pig Apolipoprotein E (APOE) Protein |
20-abx652555 |
Abbexa |
-
EUR 777.60
-
EUR 326.40
-
EUR 2397.60
-
EUR 927.60
-
EUR 560.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
APOE Protein Vector (Rat) (pPM-C-HA) |
PV254108 |
ABM |
500 ng |
EUR 723.6 |
Mouse Apolipoprotein E (APOE) Protein |
20-abx065426 |
Abbexa |
-
EUR 844.80
-
EUR 343.20
-
EUR 2598.00
-
EUR 994.80
-
EUR 594.00
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
Human Apolipoprotein E (APOE) Protein |
20-abx065429 |
Abbexa |
-
EUR 627.60
-
EUR 292.80
-
EUR 1796.40
-
EUR 727.20
-
EUR 460.80
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
APOE Protein Vector (Rat) (pPB-C-His) |
PV254106 |
ABM |
500 ng |
EUR 723.6 |
APOE Protein Vector (Rat) (pPB-N-His) |
PV254107 |
ABM |
500 ng |
EUR 723.6 |
APOE Protein Vector (Rat) (pPM-C-His) |
PV254109 |
ABM |
500 ng |
EUR 723.6 |
Biotinylated Human Apolipoprotein E / APOE3 Protein, His,Avitag™ (MALS verified) |
APE-H52E3 |
ACROBIOSYSTEMS |
25ug |
EUR 1487.3 |
|
Description: Biotinylated Human APOE3, His,Avitag (APE-H52E3) is expressed from human 293 cells (HEK293). It contains AA Lys 19 - His 317 (Accession # P02649-1). |
Biotinylated Human Apolipoprotein E / APOE2 Protein, His,Avitag™ (MALS verified) |
APE-H52E5 |
ACROBIOSYSTEMS |
25ug |
EUR 1487.3 |
|
Description: Biotinylated Human APOE2, His,Avitag (APE-H52E5) is expressed from human 293 cells (HEK293). It contains AA Lys 19 - His 317 (Accession # P02649-1 (R176C)). |
Rabbit Apolipoprotein E (APOE) Protein |
20-abx652556 |
Abbexa |
-
EUR 777.60
-
EUR 326.40
-
EUR 2397.60
-
EUR 927.60
-
EUR 560.40
|
- 100 ug
- 10 ug
- 1 mg
- 200 ug
- 50 ug
|
|
APOE Protein Vector (Human) (pPM-C-HA) |
PV002127 |
ABM |
500 ng |
EUR 394.8 |
APOE Protein Vector (Mouse) (pPM-C-HA) |
PV155300 |
ABM |
500 ng |
EUR 723.6 |
APOE Protein Vector (Human) (pPB-C-His) |
PV002125 |
ABM |
500 ng |
EUR 394.8 |
APOE Protein Vector (Human) (pPB-N-His) |
PV002126 |
ABM |
500 ng |
EUR 394.8 |
APOE Protein Vector (Human) (pPM-C-His) |
PV002128 |
ABM |
500 ng |
EUR 394.8 |
APOE Protein Vector (Mouse) (pPB-C-His) |
PV155298 |
ABM |
500 ng |
EUR 723.6 |
APOE Protein Vector (Mouse) (pPB-N-His) |
PV155299 |
ABM |
500 ng |
EUR 723.6 |
APOE Protein Vector (Mouse) (pPM-C-His) |
PV155301 |
ABM |
500 ng |
EUR 723.6 |
Recombinant Mouse ApoE/APOE/Apolipoprotein E Protein |
RP00640 |
Abclonal |
10μg |
EUR 260 |
|
APOE Protein Vector (Human) (pPB-His-MBP) |
PV322902 |
ABM |
500 ng |
EUR 394.8 |
APOE Protein Vector (Human) (pPB-His-GST) |
PV322903 |
ABM |
500 ng |
EUR 394.8 |
APOE Protein Vector (Human) (pPM-N-D-C-HA) |
PV322904 |
ABM |
500 ng |
EUR 662.4 |
APOE Protein Vector (Human) (pPM-N-D-C-His) |
PV322905 |
ABM |
500 ng |
EUR 662.4 |
Goat Anti-Human ApoE protein antiserum #1 |
APOE11-S |
Alpha Diagnostics |
100 ul |
EUR 548.4 |
Recombinant Human Apolipoprotein E/ApoE Protein |
RP00306 |
Abclonal |
10 μg |
EUR 130.8 |
APOE Recombinant Protein (Rat) |
RP190577 |
ABM |
100 ug |
Ask for price |
Recombinant Human ApoE protein W. Blot +ve control |
APOE11-C |
Alpha Diagnostics |
100 ul |
EUR 343.2 |
Recombinant Human ApoE protein W. Blot +ve control |
APOE12-C |
Alpha Diagnostics |
100 ul |
EUR 343.2 |
APOE Recombinant Protein (Human) |
RP001594 |
ABM |
100 ug |
Ask for price |
APOE Recombinant Protein (Mouse) |
RP116471 |
ABM |
100 ug |
Ask for price |
Recombinant Human ApolipoProtein E/APOE Protein, His Tag |
E40KMH686 |
EnoGene |
20ug |
EUR 495 |
Recombinant Human ApolipoProtein E/APOE Protein, His Tag |
E40KMH687 |
EnoGene |
20ug |
EUR 495 |
Recombinant Human Apolipoprotein E/ApoE Protein, His Tag |
E40KMP1509 |
EnoGene |
20ug |
EUR 495 |
Active Recombinant Human Apolipoprotein E/ApoE Protein |
RP01443 |
Abclonal |
50μg |
EUR 39 |
|
Biotinylated Human Apolipoprotein E / APOE3 (R154S) Protein, His,Avitag™ (MALS verified) |
APE-H52E4 |
ACROBIOSYSTEMS |
25ug |
EUR 1487.3 |
|
Description: Biotinylated Human APOE3 (R154S), His,Avitag (APE-H52E4) is expressed from human 293 cells (HEK293). It contains AA Lys 19 - His 317 (Accession # P02649-1 (R154S)). |
Genorise® Recombinant Mouse Apolipoprotein E (ApoE) protein |
GR124020 |
Genorise Scientific |
5 µg |
EUR 285 |
Genorise® Recombinant human Apolipoprotein E (ApoE) protein |
GR119020 |
Genorise Scientific |
5 µg |
EUR 285 |
ApolipoRecombinant Protein E / APOE Recombinant Protein |
11-256 |
ProSci |
0.1 mg |
EUR 651.3 |
Description: APOE is an apolipoprotein, a protein associating with lipid particles, that mainly functions in lipoprotein-mediated lipid transport between organs via the plasma and interstitial fluids. APOE is a core component of plasma lipoproteins and is involved in their production, conversion and clearance. Apoliproteins are amphipathic molecules that interact both with lipids of the lipoprotein particle core and the aqueous environment of the plasma. As such, APOE associates with chylomicrons, chylomicron remnants, very low density lipoproteins (VLDL) and intermediate density lipoproteins (IDL) but shows a preferential binding to high-density lipoproteins (HDL). It also binds a wide range of cellular receptors including the LDL receptor/LDLR, the LDL receptor-related proteins LRP1, LRP2 and LRP8 and the very low-density lipoprotein receptor/VLDLR that mediate the cellular uptake of the APOE-containing lipoprotein particles. |
Human ApolipoRecombinant Protein E / APOE Recombinant Protein His Tag Lyophilized |
IHUAPORHISLY100UG |
Innovative research |
each |
EUR 762 |
|
Description: Human ApolipoRecombinant Protein E / APOE Recombinant Protein His Tag Lyophilized |
APOE3 |
cyt-874 |
ProSpec Tany |
100µg |
EUR 60 |
Description: Recombinant Human Apolipoprotein E3 |
ApoE3 antibody |
70R-AR011 |
Fitzgerald |
50 ug |
EUR 392.4 |
Description: Affinity purified Rabbit polyclonal ApoE3 antibody |
ApoE3 Antibody |
5696-100 |
Biovision |
each |
EUR 392.4 |
ApoE3 Antibody |
5696-30T |
Biovision |
each |
EUR 175.2 |
ApoE2 Antibody |
5760-100 |
Biovision |
each |
EUR 392.4 |
ApoE2 Antibody |
5760-30T |
Biovision |
each |
EUR 175.2 |
ApoE3 antibody |
70R-12419 |
Fitzgerald |
100 ug |
EUR 501.6 |
Description: Rabbit polyclonal ApoE3 antibody |
ApoE2 antibody |
70R-12431 |
Fitzgerald |
100 ug |
EUR 501.6 |
Description: Rabbit polyclonal ApoE2 antibody |
ApoE3, human recombinant |
4696-100 |
Biovision |
each |
EUR 176.4 |
ApoE3, human recombinant |
4696-1000 |
Biovision |
each |
EUR 548.4 |
ApoE3, human recombinant |
4696-50 |
Biovision |
each |
EUR 157.2 |
ApoE3, human recombinant |
4696-500 |
Biovision |
each |
EUR 339.6 |
ApoE3, human recombinant |
4696-5000 |
Biovision |
each |
EUR 1854 |
ApoE2, human recombinant |
4760-100 |
Biovision |
each |
EUR 189.6 |
ApoE2, human recombinant |
4760-1000 |
Biovision |
each |
EUR 542.4 |
ApoE2, human recombinant |
4760-50 |
Biovision |
each |
EUR 151.2 |
ApoE2, human recombinant |
4760-500 |
Biovision |
each |
EUR 333.6 |
ApoE2, human recombinant |
4760-5000 |
Biovision |
each |
EUR 1776 |
Apolipoprotein E/Apo-E/APOE |
E21-J05 |
EnoGene |
10ug |
EUR 411.6 |
ApoE R2, CF |
PR15062CF |
Neuromics |
50 ug |
EUR 553.2 |
APOE |
E62B009 |
EnoGene |
20ug |
EUR 458.4 |
ApoER2 |
E8ER1803-10 |
EnoGene |
100ul |
EUR 275 |
Description: Available in various conjugation types. |
APOE siRNA |
20-abx907844 |
Abbexa |
|
|
|
APOE siRNA |
20-abx907845 |
Abbexa |
|
|
|
APOE siRNA |
20-abx900378 |
Abbexa |
|
|
|
ApoE Mouse mAb |
E2220575 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
APOE Peptide |
45-267P |
ProSci |
0.1 mg |
EUR 405.6 |
Description: APOE Peptide |
Apoe Rabbit pAb |
A16344-100ul |
Abclonal |
100 ul |
EUR 369.6 |
Apoe Rabbit pAb |
A16344-200ul |
Abclonal |
200 ul |
EUR 550.8 |
Apoe Rabbit pAb |
A16344-20ul |
Abclonal |
20 ul |
EUR 219.6 |
Apoe Rabbit pAb |
A16344-50ul |
Abclonal |
50 ul |
EUR 267.6 |
ApoE Rabbit pAb |
A12400-100ul |
Abclonal |
100 ul |
EUR 369.6 |
ApoE Rabbit pAb |
A12400-200ul |
Abclonal |
200 ul |
EUR 550.8 |
ApoE Rabbit pAb |
A12400-20ul |
Abclonal |
20 ul |
EUR 219.6 |
ApoE Rabbit pAb |
A12400-50ul |
Abclonal |
50 ul |
EUR 267.6 |
APO-E Peptide |
7333P |
ProSci |
0.05 mg |
EUR 197.7 |
Description: (CT) APO-E Peptide |
APOE Rabbit pAb |
A0304-100ul |
Abclonal |
100 ul |
EUR 369.6 |
APOE Rabbit pAb |
A0304-200ul |
Abclonal |
200 ul |
EUR 550.8 |
APOE Rabbit pAb |
A0304-20ul |
Abclonal |
20 ul |
EUR 219.6 |
APOE Rabbit pAb |
A0304-50ul |
Abclonal |
50 ul |
EUR 267.6 |
Rat APOE ELISA Kit |
ERA0526 |
Abclonal |
96Tests |
EUR 625.2 |
ApoE Rabbit pAb |
E2382441 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
APOE Rabbit pAb |
E2500304 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
Apoe Rabbit pAb |
E2516344 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
ApoE antibody |
10R-10633 |
Fitzgerald |
100 ug |
EUR 418.8 |
Description: Mouse monoclonal ApoE antibody |
ApoE antibody |
10R-2370 |
Fitzgerald |
50 ug |
EUR 486 |
Description: Mouse monoclonal Apolipoprotein E antibody |
ApoE antibody |
10R-A136a |
Fitzgerald |
50 ug |
EUR 501.6 |
Description: Mouse monoclonal ApoE antibody |
ApoE antibody |
20-S1161G000-V0 |
Fitzgerald |
10 ml |
EUR 243.6 |
Description: Goat polyclonal ApoE antibody |
APO-E Antibody |
7333-002mg |
ProSci |
0.02 mg |
EUR 206.18 |
|
Description: APO-E Antibody: Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E (APO-E), a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. Defects in APO-E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. |
APO-E Antibody |
7333-01mg |
ProSci |
0.1 mg |
EUR 523.7 |
|
Description: APO-E Antibody: Chylomicron remnants and very low density lipoprotein (VLDL) remnants are rapidly removed from the circulation by receptor-mediated endocytosis in the liver. Apolipoprotein E (APO-E), a main apoprotein of the chylomicron, binds to a specific receptor on liver cells and peripheral cells and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. Defects in APO-E result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. |
ApoE antibody |
70C-CR9016GAP |
Fitzgerald |
100 ug |
EUR 164.4 |
Description: Affinity purified Goat polyclonal Apo E antibody |
ApoE antibody |
70C-CR90GAP |
Fitzgerald |
100 ug |
EUR 289.2 |
Description: Purified Polyclonal Goat ApoE antibody |
ApoE Antibody (CT) |
6720-100 |
Biovision |
each |
EUR 379.2 |
ApoE antibody |
70R-5264 |
Fitzgerald |
50 ug |
EUR 560.4 |
Description: Rabbit polyclonal ApoE antibody raised against the N terminal of APOE |
APOE Antibody |
35301-100ul |
SAB |
100ul |
EUR 302.4 |
APOE Antibody |
35301-50ul |
SAB |
50ul |
EUR 224.4 |
APOE Antibody |
1-CSB-PA009485 |
Cusabio |
|
|
|
Description: A polyclonal antibody against APOE. Recognizes APOE from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: WB, IHC, ELISA;WB:1/500-1/2000.IHC:1/100-1/300.ELISA:1/10000 |
APOE Antibody |
1-CSB-PA009486 |
Cusabio |
|
|
|
Description: A polyclonal antibody against APOE. Recognizes APOE from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000 |
APOE Antibody |
CSB-PA227407- |
Cusabio |
each |
EUR 402 |
|
Description: A polyclonal antibody against APOE. Recognizes APOE from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
APOE Antibody |
CSB-PA227407-100ul |
Cusabio |
100ul |
EUR 379.2 |
|
Description: A polyclonal antibody against APOE. Recognizes APOE from Human. This antibody is Unconjugated. Tested in the following application: ELISA, WB;WB:1:500-1:3000 |
APOE Antibody |
1-CSB-PA07599A0Rb |
Cusabio |
|
|
|
Description: A polyclonal antibody against APOE. Recognizes APOE from Human. This antibody is Unconjugated. Tested in the following application: ELISA, IHC, IF; Recommended dilution: IHC:1:1000-1:2000, IF:1:200-1:500 |
Apoe Antibody |
1-CSB-PA001936LA01MO |
Cusabio |
|
|
|
Description: A polyclonal antibody against Apoe. Recognizes Apoe from Mouse. This antibody is Unconjugated. Tested in the following application: ELISA, WB; Recommended dilution: WB:1:1000-1:5000 |
Goat APOE ELISA Kit |
EGTA0526 |
Abclonal |
96Tests |
EUR 625.2 |
APOE Antibody |
R36329-100UG |
NSJ Bioreagents |
100 ug |
EUR 339.15 |
Description: Additional name(s) for this target protein: Apolipoprotein E |
ApoE Antibody |
R31740 |
NSJ Bioreagents |
100 ug |
EUR 356.15 |
Description: Apolipoprotein E, also known as AD2 or LPG, is a major apoprotein of the chylomicron. It binds to a specific liver and peripheral cell receptor, and is essential for the normal catabolism of triglyceride-rich lipoprotein constituents. The gene maps to chromosome 19 in a cluster with the related apolipoprotein C1 and C2 genes. Mutations in ApoE result in familial dysbetalipoproteinemia, or type III hyperlipoproteinemia (HLP III), in which increased plasma cholesterol and triglycerides are the consequence of impaired clearance of chylomicron and VLDL remnants. Alternative splicing results in multiple ApoE transcript variants. |
APOE Antibody |
E11-21238C |
EnoGene |
100μg |
EUR 225 |
Description: Available in various conjugation types. |
APOE Antibody |
E035301 |
EnoGene |
100μg/100μl |
EUR 255 |
Description: Available in various conjugation types. |
ApoE Antibody |
E10-30215 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
APOE Antibody |
E19-4797 |
EnoGene |
100μg/100μl |
EUR 225 |
Description: Available in various conjugation types. |
ApoE Antibody |
E80809-6 |
EnoGene |
100μl |
EUR 225 |
Description: Available in various conjugation types. |
Mouse APOE ELISA Kit |
EMA0526 |
Abclonal |
96Tests |
EUR 625.2 |
Sheep APOE ELISA Kit |
ESA0526 |
Abclonal |
96Tests |
EUR 625.2 |
Human APOE ELISA Kit |
EHA0526 |
Abclonal |
96Tests |
EUR 625.2 |
Mouse ApoE ELISA Kit |
IMSAPOEKT |
Innovative research |
each |
EUR 446 |
|
Description: Mouse ApoE ELISA Kit |
Human ApoE ELISA Kit |
STA-367 |
Cell Biolabs |
96 assays |
EUR 866.4 |
Description: The Human ApoE ELISA Kit is an enzyme immunoassay developed for the detection and quantitation of human apolipoprotein in plasma, serum or other biological fluid samples. Each kit provides sufficient reagents to perform up to 96 assays including standard curve and unknown samples. |
Human APOE ELISA Kit |
STJ150123 |
St John's Laboratory |
1 kit |
EUR 494.4 |
Description: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of ApoE in human serum, plasma and other biological fluids |
Mouse APOE ELISA Kit |
STJ150264 |
St John's Laboratory |
1 kit |
EUR 494.4 |
Description: The kit is a sandwich enzyme immunoassay for in vitro quantitative measurement of APO-E in Mouse serum, plasma and other biological fluids |
ApoER2 Rabbit pAb |
E2382013 |
EnoGene |
100ul |
EUR 225 |
Description: Available in various conjugation types. |
ApoER2 Rabbit mAb |
E2R23500 |
EnoGene |
100ul |
EUR 255 |
Description: Available in various conjugation types. |
Human apoE ELISA KIT |
E42EH-76 |
EnoGene |
96T/48T |
Ask for price |
ApoER2 antibody |
70R-51036 |
Fitzgerald |
100 ul |
EUR 292.8 |
Description: Purified Polyclonal ApoER2 antibody |
Right here we current PAWER, the web internet device devoted solely to protein microarray evaluation. PAWER permits biologists to hold out all the required evaluation steps in a single go. PAWER offers entry to state-of-the-art computational strategies by means of the user-friendly interface, leading to publication-ready illustrations. We additionally present an R bundle for extra superior use circumstances, reminiscent of bespoke evaluation workflows.